These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 32853206)
1. Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment. Miranda VHS; Gomes TR; Eller DE; Ferraz LCN; Chaves AT; Bicalho KA; Silva CEC; Birbrair A; Pascoal Xavier MA; de Goes AM; Corrêa-Oliveira R; Alves ÉAR; Bozzi A PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008635. PubMed ID: 32853206 [TBL] [Abstract][Full Text] [Related]
2. Dandelion (Taraxacum officinale) Improves the Therapeutic Efficiency of Praziquantel in Experimental Schistosomiasis. Atwa MTM; Abd-Elrazek AM; Salem NIS Acta Parasitol; 2022 Jun; 67(2):773-783. PubMed ID: 35067863 [TBL] [Abstract][Full Text] [Related]
3. Dietary glycemic and energy load differentially modulates Schistosoma mansoni-induced granulomatous inflammation and response to antiparasitic chemotherapy. Reis LFCD; Cerdeira CD; Silva LCC; Ramos ABSB; Silva JEC; Castro AP; Ventura RR; Souza RLM; Marques MJ; Novaes RD Acta Trop; 2024 Apr; 252():107141. PubMed ID: 38342286 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy. Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014 [TBL] [Abstract][Full Text] [Related]
5. Cysteinyl leukotriene receptor-1 as a potential target for host-directed therapy during chronic schistosomiasis in murine model. Mosala P; Mpotje T; Abdel Aziz N; Ndlovu H; Musaigwa F; Nono JK; Brombacher F Front Immunol; 2024; 15():1279043. PubMed ID: 38840916 [TBL] [Abstract][Full Text] [Related]
6. The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice. Mohamed AH; Osman GY; Salem TA; Elmalawany AM Exp Parasitol; 2014 Oct; 145():7-13. PubMed ID: 25016189 [TBL] [Abstract][Full Text] [Related]
7. Light and electron microscopic studies on Schistosoma mansoni Granulomas of mouse livers following treatment with praziquantel. Mehlhorn H; Frenkel JK; Andrews P; Thomas H Tropenmed Parasitol; 1982 Dec; 33(4):229-39. PubMed ID: 6891845 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel. Yepes E; Varela-M RE; López-Abán J; Rojas-Caraballo J; Muro A; Mollinedo F PLoS Negl Trop Dis; 2015; 9(7):e0003893. PubMed ID: 26191954 [TBL] [Abstract][Full Text] [Related]
9. Protein undernutrition reduces the efficacy of praziquantel in a murine model of Schistosoma mansoni infection. Kadji Fassi JB; Boukeng Jatsa H; Membe Femoe U; Greigert V; Brunet J; Cannet C; Kenfack CM; Gipwe Feussom N; Tienga Nkondo E; Abou-Bacar A; Pfaff AW; Kamgang R; Kamtchouing P; Tchuem Tchuenté LA PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010249. PubMed ID: 35839247 [TBL] [Abstract][Full Text] [Related]
10. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Morcos SH; Khayyal MT; Mansour MM; Saleh S; Ishak EA; Girgis NI; Dunn MA Am J Trop Med Hyg; 1985 Mar; 34(2):314-21. PubMed ID: 3985273 [TBL] [Abstract][Full Text] [Related]
11. Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection. Membe Femoe U; Boukeng Jatsa H; Greigert V; Brunet J; Cannet C; Kenfack MC; Gipwe Feussom N; Kadji Fassi JB; Tienga Nkondo E; Abou-Bacar A; Pfaff AW; Dimo T; Kamtchouing P; Tchuem Tchuenté LA PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010382. PubMed ID: 35446855 [TBL] [Abstract][Full Text] [Related]
12. Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study. Mahmoud TY; Rizk SM; Maghraby AS; Shaheen AA Parasitol Res; 2014 Dec; 113(12):4513-23. PubMed ID: 25266217 [TBL] [Abstract][Full Text] [Related]
13. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz. Morsy GH J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775 [TBL] [Abstract][Full Text] [Related]
14. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile. Farid A; Malek AA; Rabie I; Helmy A; El Amir AM Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier. Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833 [TBL] [Abstract][Full Text] [Related]